Countries Hong Kong
Sirnaomics Forms Strategic Partnership with EDIRNA Inc. in RNA-Editing Therapeutics
EDIRNA is a start-up biotech company focusing on RNA-Editing therapeutics and taking advantage of the Group's proprietary technology platforms for novel RN...
July 06, 2023 | News
Gilead Sciences and IAS Honor Global Healthcare Providers for Stigma-Free HIV Services
The 2023 Me and My Healthcare Provider (MMHCP) campaign, supported by Gilead for the second year running, honours frontline workers providing exemplary inc...
July 05, 2023 | News
AI-Designed Drug Enters Phase II Trials, First Patients Dosed by Insilico Medicine
After completing the Phase 0 and Phase I human safety studies, INS018_055, Insilico's AI-discovered and AI-generated drug, has ent...
June 28, 2023 | News
Hong Kong Polytechnic University researchers develop Optoelectronic Graded Neurons
he tiny visual systems of flying insects have inspired researchers of the Hong Kong Polytechnic University (PolyU) to develop Optoelectronic Graded Neurons...
June 28, 2023 | News
Prenetics and Prof. Dennis Lo Launch US$200m Joint Venture "Insighta" for Multi-Cancer Early Detection
- Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics w...
June 26, 2023 | News
Brii Biosciences to Sell Equity Interest in Qpex Biopharma and Acquire Global Rights for BRII-693
Company acquires exclusive global rights of the novel lipopeptide BRII-693 for the difficult to treat MDR/XDR gram-negative bacterial infections &nbs...
June 26, 2023 | News
Sirnaomics Advances STP705 for SCCIS into Late-Stage Clinical Development
The FDA provided Sirnaomics guidance to move forward with late-stage clinical development because of the efficacious data provided as well as the widesprea...
June 20, 2023 | News
Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million
Based on its SBDD strategy, Viva Biotech has achieved remarkable growth in its CRO drug discovery and development business through its continuous effort th...
June 16, 2023 | News
Sirnaomics to Unveil GalAhead™ Therapeutic Platform Updates at Industry Conferences
The Company's first GalAhead™-based RNAi drug candidate, STP122G, has started a Phase I clinical trial in May 2023. The start of the trial indic...
June 14, 2023 | News
HKSH Medical Group and UCLA Health signed a Development Agreement
HKSH Medical Group (HKSH) and UCLA Health have signed a Development Agreement to strengthen their partnership in knowledge transfer in cancer management. T...
June 13, 2023 | News
Chinese Medical Development Led by Hong Kong Dragon's Medical and Reproductive Giants
Dragon's Medical successfully held its Advance Medical Technology Press Conference 2023 at W Hong Kong, signing strategic partnership agreements with ...
June 12, 2023 | News
Antengene's ATG-022 Receives Orphan Drug Designations for Gastric and Pancreatic Cancers
Orphan Drugs, also known as Rare Disease Drugs, refers to pharmaceutical products developed for the prevention, diagnosis, and treatment of rare diseases o...
May 24, 2023 | News
Antengene Clears U.S. IND for Phase I Trial of ATG-031 Antibody
- ATG-031, discovered and developed in-house by Antengene, is the world's first anti-CD24 antibody to advance to the clinic in oncolog...
May 18, 2023 | News
Sirnaomics to Receive HK$8M Subsidy for Clinical Translational Catalyst Plan
The subsidy comes under HKSTP's Clinical Translational Catalyst ("CTC") programme dedicated to catalysing clinical translation to bring innovative, life-ch...
May 18, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
